Fachbeirat des Instituts

Um die hohe Qualität der wissenschaftlichen Forschung zu gewährleisten, werden alle Institute der Max-Planck-Gesellschaft regelmäßig von unabhängigen Fachbeiräten begutachtet. Deren Mitglieder sind Experten von weltweit führenden Forschungseinrichtungen und Universitäten. Der Max-Planck-Präsident ernennt die Mitglieder auf der Basis von Vorschlägen des Instituts. Sie werden für eine Amtszeit von maximal sechs Jahren berufen.

Unser Fachbeirat umfasst die folgenden 24 Mitglieder:

  • Prof. Dr. Julie Ahringer
    Wellcome Trust/Cancer Research UK Gurdon Institute, Cambridge, UK
  • Prof. Dr. Peer Bork,
    Structural and Computational Biology, EMBL Heidelberg, Germany
  • Prof. Dr. Cynthia J. Burrows,
    Department of Chemistry, The University of Utah, USA
  • Prof. Dr. David W. Chandler,
    Sandia National Laboratories, California, USA
  • Prof. Dr. Graeme Davis,
    Department of Biochemistry and Biophysics, University of California, San Francisco, USA
  • Prof. Dr. Thomas W. Ebbesen,
    ISIS, Laboratoire des Nanostructures, Strasbourg Cedex, France
    Prof. Dr. Witold Filipowicz,
    Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland
    Prof. Dr. Lucio Frydman
    Department of Chemical and Biological Physics, Weizmann Institute of Science, Rehovot, Israel
  • Prof. Dr. Yukiko Goda, 
    Laboratory for Synaptic Plasticity and Connectivity, RIKEN Brain Science Institute, Saitama, Japan
  • Prof. Dr. Astrid Gräslund,
    Department of Biochemistry and Biophysics, Stockholm University, Stockholm, Sweden
  • Prof. Dr. Angela Gronenborn,
    Department of Structural Biology, University of Pittsburgh, Pittsburgh, USA
  • Prof. Dr. Rebecca W. Heald,
    Department of Molecular & Cell Biology, University of California, Berkeley, USA
  • Prof. Dr. Johan Hofkens,
    Molecular Imaging and Photonics, KU Leuven, Leuven, Belgium
  • Prof. Dr. Laurinda Jaffe,
    School of Medicine, University of Connecticut, Farmington, USA
  • Prof. Dr. Ute Kaiser,
    Electron Microscopy Group of Materials Science, Universität Ulm, Germany
  • Prof. Dr. Kinneret Keren,
    Physics Department, Technion – Israel Institute of Technology, Haifa, Israel
  • Prof. Dr. Iain Mattaj, (CHAIR)
    Fondazione Human Technopole, Milano, Italy
  • Prof. Dr. Ann McDermott,
    Department of Chemistry, Columbia University, New York, USA
  • Prof. Dr. Jane Mellor,
    Deparment of Biochemistry, University of Oxford, Oxford, UK
  • Prof. Dr. Daniel M. Neumark,
    College of Chemistry, University of California, Berkeley, USA
  • Prof. Dr. Anna Marie Pyle,
    Biological & Biomedical Sciences, Yale University, New Haven, USA
  • Prof. Dr. Bruce R. Ransom,
    Lo Kwee-Seong Integrated Biomedical Sciences, School of Biomedical Sciences, Chinese University of Hong Kong, Hong Kong
  • Prof. Dr. José Rizo-Rey,
    Department of Biophysics, Medical Center, University of Texas Southwestern Medical Center, Dallas, USA
  • Prof. Dr. Randy Schekman,
    Department of Molecular and Cell Biology, University of California, Berkeley, USA
  • Prof. Dr. Thomas U. Schwartz,
    Department of Biology, Massachussetts Institute of Technology, Cambridge, USA
  • Prof. Dr. Jeremy C. Smith, 
    Oak Ridge National Laboratory, Oak Ridge, USA
  • Prof. Dr. Beth Stevens,
    Boston Children’s Hospital, Harvard Medical School, Boston, USA
  • Prof. Dr. Peter Tielemann,
    Biochemistry Biocomputing Group, University of Calgary, Calgary, Canada
  • Prof. Dr. Joachim Wittbrodt,
    Centre for Organismal Studies, Ruprecht-Karls-Universität Heidelberg, Heidelberg, Germany
Zur Redakteursansicht